ARISTEIA CAPITAL, L.L.C. - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V116. A total of 15 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ARISTEIA CAPITAL, L.L.C. ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$161,276
-37.9%
1,493,292
-0.3%
0.00%
-33.3%
Q2 2023$259,850
+69.7%
1,497,695
-2.8%
0.01%
+50.0%
Q1 2023$153,106
-12.1%
1,540,2970.0%0.00%
+33.3%
Q4 2022$174,208
-34.0%
1,540,297
-1.1%
0.00%
-40.0%
Q3 2022$264,000
-30.3%
1,557,474
-3.5%
0.01%
-28.6%
Q2 2022$379,000
-40.2%
1,614,0870.0%0.01%
-36.4%
Q1 2022$634,000
-58.9%
1,614,087
-6.8%
0.01%
-59.3%
Q4 2021$1,541,000
-45.8%
1,731,946
-1.0%
0.03%
-49.1%
Q3 2021$2,844,0001,750,0000.05%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Evolution Capital Management LLC 50,000$10,0000.02%
ARISTEIA CAPITAL, L.L.C. 1,557,474$264,0000.01%
LITTLEJOHN & CO LLC 16,666$3,0000.00%
MMCAP International Inc. SPC 145,941$30,0000.00%
WHITEBOX ADVISORS LLC 298,145$61,0000.00%
Parallel Advisors, LLC 64,166$13,0000.00%
CVI Holdings, LLC 49,738$10,0000.00%
III Capital Management 41,795$7,0000.00%
Tower Research Capital LLC (TRC) 23$00.00%
Jefferies Group LLC 10,000$2,0340.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders